glp-1 agonist or antagonist Trends in the Development of Receptor Agonists DPP4 Inhibitors vs GLP-1 Agonists
Description
In a pilot trial evaluating 104 amnestic MCI and early-stage AD patients, 20 IU and 40 IU doses of intranasal insulin improved Alzheimers Disease Assessment Scale-Cognitive subscale (ADAS-Cog 12) scores compared to placebo-treated patients, with improvements in delayed recall observed 2 months following cessation of treatment in the 20 IU group
Similar results were reported in STEP-HFpEF DM, which included patients with diabetes excluded in STEP-HFpEF [30]
What would you tell someone who is considering this practice
For those who prefer not to use injections, semaglutide is also available in tablet form
[DOI] [PubMed] 106
2,3 Since then, multiple meta-analyses, using data collected from large-scale cardiovascular outcome trials and the U.S
